Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

60.74
+0.88001.47%
Post-market: 60.45-0.2900-0.48%19:57 EST
Volume:10.82M
Turnover:656.45M
Market Cap:123.65B
PE:17.55
High:60.95
Open:60.11
Low:60.02
Close:59.86
52wk High:63.33
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.78
T/O Rate:0.53%
Dividend:2.49
Dividend Rate:4.10%
EPS(TTM):3.46
EPS(LYR):3.46
ROE:40.33%
ROA:9.39%
PB:6.67
PE(LYR):17.55

Loading ...

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Yesterday

Bristol Myers’ treatment of follicular lymphoma granted FDA orphan designation

TIPRANKS
·
Yesterday

BMY-Backed Milvexian Stroke Trial Moves Forward, Keeping Upside Optionality Alive

TIPRANKS
·
Yesterday

Bristol-Myers Squibb Expands Real-World MDS Footprint in Asia With New Registry Study

TIPRANKS
·
Yesterday

Bristol-Myers Squibb: Solid Near-Term Execution and 2026 EPS Boost from Eliquis, but Limited Long-Term Visibility Supports Hold Rating

TIPRANKS
·
Feb 10

AstraZeneca Signs Global Rights Agreement With CSPC for Injectable Weight Management Portfolio

Reuters
·
Feb 10

Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Feb 10

Bristol-Myers Squibb Is Maintained at Buy by Guggenheim

Dow Jones
·
Feb 06

BUZZ-Street View: Bristol Myers Squibb drug pipeline in focus as key patent expiry looms

Reuters
·
Feb 06

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Resmed (RMD) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Feb 06

Bristol-Myers Squibb Company : Wells Fargo Raises Target Price to $60 From $55

THOMSON REUTERS
·
Feb 06

Bristol-Myers Squibb Co : Citigroup Raises Target Price to $64 From $60

THOMSON REUTERS
·
Feb 06

Bristol-Myers Squibb Co : Morgan Stanley Raises Target Price to $40 From $37

THOMSON REUTERS
·
Feb 06

U.S. RESEARCH ROUNDUP-Amazon, Estée Lauder, Ralph Lauren

Reuters
·
Feb 06

Reiterating Buy on Bristol-Myers Squibb: Milvexian’s Validated FXIa Mechanism and Underappreciated Stroke Prevention Upside Support $65 Target

TIPRANKS
·
Feb 06

Truist incrementally positive on Bristol Myers after Bayer asundexian data

TIPRANKS
·
Feb 06

JPMorgan Raises Bristol-Myers Squibb Price Target to $67 From $65

MT Newswires Live
·
Feb 06

BUZZ-U.S. STOCKS ON THE MOVE-Netflix, FirstCash Holdings, CF Bankshares

Reuters
·
Feb 06

Dow Tumbles Over 400 Points; Bristol Myers Reports Strong Q4 Results

Benzinga_recent_news
·
Feb 06

Bayer Says Asundexian Study Showed No Increase in the Risk of Major Bleeding

THOMSON REUTERS
·
Feb 06